These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2839542

  • 21. Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily "binge" intragastric alcohol administration.
    Zhou Y, Franck J, Spangler R, Maggos CE, Ho A, Kreek MJ.
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1575-82. PubMed ID: 11045867
    [Abstract] [Full Text] [Related]

  • 22. In vitro corticotropin-releasing hormone (CRH) stimulation of adrenocorticotropin release from corticotroph adenoma cells: effect of prolonged exposure to CRH and its interaction with cortisol.
    Grino M, Boudouresque F, Conte-Devolx B, Gunz G, Grisoli F, Oliver C, Jaquet P.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):770-5. PubMed ID: 2831247
    [Abstract] [Full Text] [Related]

  • 23. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone.
    Parsadaniantz SM, Batsché E, Gegout-Pottie P, Terlain B, Gillet P, Netter P, Kerdelhué B.
    Neuroendocrinology; 1997 Jan; 65(1):53-63. PubMed ID: 9032774
    [Abstract] [Full Text] [Related]

  • 24. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
    Pecori Giraldi F, Bucciarelli LG, Saccani A, Scacchi M, Pesce S, Losa M, Cavagnini F.
    J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of antisense DNA on POMC mRNA and ACTH levels in cultured human corticotroph adenoma cells.
    Woloschak M, Post K, Roberts JL.
    J Endocrinol Invest; 1994 Nov; 17(10):817-9. PubMed ID: 7699217
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Aberrant production and regulation of proopiomelanocortin-derived peptides in ectopic Cushing's syndrome.
    Roth KA, Newell DC, Dorin RI, Eberwine JH, Hoffman AR.
    Horm Metab Res; 1988 Apr; 20(4):225-9. PubMed ID: 2456259
    [Abstract] [Full Text] [Related]

  • 31. Complex transcriptional regulation by glucocorticoids and corticotropin-releasing hormone of proopiomelanocortin gene expression in rat pituitary cultures.
    Eberwine JH, Jonassen JA, Evinger MJ, Roberts JL.
    DNA; 1987 Oct; 6(5):483-92. PubMed ID: 3500023
    [Abstract] [Full Text] [Related]

  • 32. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
    Farrell WE, Stewart MF, Clark AJ, Crosby SR, Davis JR, White A.
    J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
    [Abstract] [Full Text] [Related]

  • 33. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
    Margioris AN, Grino M, Protos P, Gold PW, Chrousos GP.
    J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
    [Abstract] [Full Text] [Related]

  • 34. CRH and AVP-induced changes in synthesis and release of ACTH from the ovine fetal pituitary in vitro: negative influences of cortisol.
    Matthews SG, Challis JR.
    Endocrine; 1997 Jun; 6(3):293-300. PubMed ID: 9368686
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids.
    Gagner JP, Drouin J.
    Mol Endocrinol; 1987 Oct; 1(10):677-82. PubMed ID: 2856398
    [Abstract] [Full Text] [Related]

  • 37. A Pituitary cell type coexpressing messenger ribonucleic acid of proopiomelanocortin and the glycoprotein hormone alpha-subunit in neonatal rat and chicken: rapid decline with age and reappearance in vitro under regulatory pressure of corticotropin-releasing hormone in the rat.
    Pals K, Boussemaere M, Swinnen E, Vankelecom H, Denef C.
    Endocrinology; 2006 Oct; 147(10):4738-52. PubMed ID: 16840545
    [Abstract] [Full Text] [Related]

  • 38. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S, Crosby SR, Stewart MF, Jennings AM, McCall E, White A.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [Abstract] [Full Text] [Related]

  • 39. Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone.
    Asaba K, Makino S, Hashimoto K.
    Brain Res; 1998 Sep 21; 806(1):95-103. PubMed ID: 9739115
    [Abstract] [Full Text] [Related]

  • 40. Hemodynamic actions of corticotropin-releasing hormone and proopiomelanocortin derivatives in septic patients.
    Matejec R, Löcke G, Kayser F, Lichtenstern C, Weigand MA, Welters ID, Bödeker RH, Harbach HW.
    J Cardiovasc Pharmacol; 2011 Jan 21; 57(1):94-102. PubMed ID: 20980919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.